IL71319A - (1h-tetrazol-5-yl)-2(1h)-quinolinones,process for their preparation and pharmaceutical compositions containing the same - Google Patents
(1h-tetrazol-5-yl)-2(1h)-quinolinones,process for their preparation and pharmaceutical compositions containing the sameInfo
- Publication number
- IL71319A IL71319A IL71319A IL7131984A IL71319A IL 71319 A IL71319 A IL 71319A IL 71319 A IL71319 A IL 71319A IL 7131984 A IL7131984 A IL 7131984A IL 71319 A IL71319 A IL 71319A
- Authority
- IL
- Israel
- Prior art keywords
- tetrazol
- quinolinones
- preparation
- same
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Laminated Bodies (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/478,965 US4735948A (en) | 1983-03-25 | 1983-03-25 | (1H-tetrazol-5-yl)-2(1H)-quinolinones and-naphthyridones and antiallergic use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL71319A0 IL71319A0 (en) | 1984-06-29 |
| IL71319A true IL71319A (en) | 1988-03-31 |
Family
ID=23902120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL71319A IL71319A (en) | 1983-03-25 | 1984-03-22 | (1h-tetrazol-5-yl)-2(1h)-quinolinones,process for their preparation and pharmaceutical compositions containing the same |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4735948A (no) |
| EP (1) | EP0120483B1 (no) |
| JP (1) | JPS59176276A (no) |
| KR (1) | KR900003650B1 (no) |
| AT (1) | ATE26276T1 (no) |
| AU (1) | AU562115B2 (no) |
| CA (1) | CA1241001A (no) |
| DE (1) | DE3462895D1 (no) |
| DK (1) | DK163238C (no) |
| ES (1) | ES8601963A1 (no) |
| GR (1) | GR81908B (no) |
| IE (1) | IE57073B1 (no) |
| IL (1) | IL71319A (no) |
| NO (1) | NO841157L (no) |
| NZ (1) | NZ207581A (no) |
| PT (1) | PT78289B (no) |
| ZA (1) | ZA842065B (no) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT79031B (en) * | 1983-08-20 | 1986-08-22 | Boots Co Plc | Therapeutic agents |
| US5358949A (en) * | 1986-03-05 | 1994-10-25 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives |
| US4916131A (en) * | 1986-10-15 | 1990-04-10 | Schering Corporation | Naphthyridine derivatives and method for treating allergic reactions |
| EP0267691A3 (en) * | 1986-10-15 | 1989-08-23 | Schering Corporation | Use of 1-substituted naphthyridine and pyridopyrazine derivatives for the preparation of medicaments with immunosuppressor activity. |
| US5037826A (en) * | 1986-10-15 | 1991-08-06 | Schering Corporation | 1-substituted naphthyridine and pyridopyrazine derivatives |
| US5064837A (en) * | 1989-11-13 | 1991-11-12 | Schering Corporation | 3-substituted-1-aryl-2(h)-quinolones and their pharmaceutical compositions |
| GB9026389D0 (en) * | 1990-12-05 | 1991-01-23 | Merck Sharp & Dohme | Therapeutic agents |
| GB9125485D0 (en) * | 1991-11-29 | 1992-01-29 | Merck Sharp & Dohme | Therapeutic agents |
| US5658924A (en) * | 1992-12-01 | 1997-08-19 | The Green Cross Corporation | 1,8-naphthyridin-2-one derivative and use thereof |
| DE19727410A1 (de) * | 1997-06-27 | 1999-01-07 | Hoechst Schering Agrevo Gmbh | 3-(5-Tetrazolylcarbonyl)-2-chinolone und diese enthaltende nutzpflanzenschützende Mittel |
| GB0316546D0 (en) | 2003-07-15 | 2003-08-20 | Novartis Ag | Process for the manufacture of organic compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1444369A (en) * | 1973-04-05 | 1976-07-28 | Allen & Hanburys Ltd | 1,8-naphthyridines |
| US3993656A (en) * | 1974-11-19 | 1976-11-23 | Merck & Co., Inc. | 1,8-Naphthyridine compounds |
| US4035368A (en) * | 1975-04-02 | 1977-07-12 | Riker Laboratories, Inc. | Substituted 3-(1H-tetrazol-5-yl)-quinoline compounds |
| US4350817A (en) * | 1980-02-28 | 1982-09-21 | American Home Products Corporation | 4-Cl, Br or I-3-Carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives |
| NZ212209A (en) * | 1984-05-29 | 1988-08-30 | Pfizer | Quinolone derivatives and pharmaceutical compositions |
-
1983
- 1983-03-25 US US06/478,965 patent/US4735948A/en not_active Expired - Lifetime
-
1984
- 1984-03-20 CA CA000449959A patent/CA1241001A/en not_active Expired
- 1984-03-20 ZA ZA842065A patent/ZA842065B/xx unknown
- 1984-03-21 GR GR74164A patent/GR81908B/el unknown
- 1984-03-21 NZ NZ207581A patent/NZ207581A/en unknown
- 1984-03-21 PT PT78289A patent/PT78289B/pt not_active IP Right Cessation
- 1984-03-21 AU AU25952/84A patent/AU562115B2/en not_active Ceased
- 1984-03-22 JP JP59053691A patent/JPS59176276A/ja active Granted
- 1984-03-22 IL IL71319A patent/IL71319A/xx unknown
- 1984-03-22 ES ES530877A patent/ES8601963A1/es not_active Expired
- 1984-03-23 DE DE8484103231T patent/DE3462895D1/de not_active Expired
- 1984-03-23 DK DK165684A patent/DK163238C/da not_active IP Right Cessation
- 1984-03-23 IE IE720/84A patent/IE57073B1/en not_active IP Right Cessation
- 1984-03-23 EP EP84103231A patent/EP0120483B1/en not_active Expired
- 1984-03-23 NO NO841157A patent/NO841157L/no unknown
- 1984-03-23 AT AT84103231T patent/ATE26276T1/de active
- 1984-03-24 KR KR1019840001514A patent/KR900003650B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA1241001A (en) | 1988-08-23 |
| DK165684D0 (da) | 1984-03-23 |
| KR840008153A (ko) | 1984-12-13 |
| JPS59176276A (ja) | 1984-10-05 |
| US4735948A (en) | 1988-04-05 |
| KR900003650B1 (ko) | 1990-05-28 |
| ES530877A0 (es) | 1985-11-01 |
| NZ207581A (en) | 1987-01-23 |
| ES8601963A1 (es) | 1985-11-01 |
| AU2595284A (en) | 1984-09-27 |
| EP0120483A1 (en) | 1984-10-03 |
| PT78289A (en) | 1984-04-01 |
| IE840720L (en) | 1984-09-25 |
| PT78289B (en) | 1986-04-22 |
| ATE26276T1 (de) | 1987-04-15 |
| EP0120483B1 (en) | 1987-04-01 |
| ZA842065B (en) | 1984-10-31 |
| IE57073B1 (en) | 1992-04-22 |
| JPH0452273B2 (no) | 1992-08-21 |
| DK165684A (da) | 1984-09-26 |
| IL71319A0 (en) | 1984-06-29 |
| AU562115B2 (en) | 1987-05-28 |
| DE3462895D1 (de) | 1987-05-07 |
| NO841157L (no) | 1984-09-26 |
| DK163238C (da) | 1992-06-29 |
| GR81908B (no) | 1984-12-12 |
| DK163238B (da) | 1992-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8307794A1 (es) | Un procedimiento para la preparacion de agentes antifugicos triazolicos. | |
| AU536920B2 (en) | Hydroxypropyl-triazole derivatives and their use as antimycotic agents | |
| IL71319A (en) | (1h-tetrazol-5-yl)-2(1h)-quinolinones,process for their preparation and pharmaceutical compositions containing the same | |
| JO1406B1 (en) | Chemical compounds | |
| PT84716A (en) | Process for the preparation of insecticidal compositions containing six-membered heterocyclic derivatives of n:-substituted-n,n:-diacylhydrazines | |
| ES8604520A1 (es) | Procedimiento para preparar derivados de 2(1h)-piridona | |
| ES472640A1 (es) | Procedimiento para preparar seudotrisacaridos | |
| AU539847B2 (en) | 3,4,5-trihydroxypiperidine compounds | |
| ZA836480B (en) | Substituted tert.-butanol derivatives,processes for their preparation and antimycotic agents containing these compounds | |
| IL66028A0 (en) | Saturated aminocyclitol derivatives,their preparation and pharmaceutical compositions containing them | |
| IL71318A (en) | (1h-tetrazol-5-yl)tetrazolo(1,5-a)quinolines and related compounds,their preparation and antiallergic pharmaceutical compositions containing them | |
| DE3062620D1 (en) | Class of bis-indole compounds useful as medicines, and process for their preparation | |
| ES474052A1 (es) | Procedimiento para la obtencion de 1,4-dihidropiridazinas 1-n-sustituidas. | |
| ES8505357A1 (es) | Un procedimiento para la preparacion de derivados de carboxi-tiazolo (3,2-a) pirimidina nuevos | |
| ES8800198A1 (es) | Procedimiento para preparar derivados de acidos aziridin-2- carboxilicos substituidos en n | |
| ATE41003T1 (de) | Tetrazolothienopyridine. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Change of name of proprietor(s) |
Owner name: AVENTIS INC. Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC. |